Bioequivalence of a Fixed Dose Combination Tablet Containing 200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl Compared to RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) as a Fixed Dose Combination Tablet Administered in Healthy Volunteers.

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

September 30, 2010

Conditions
Healthy
Interventions
DRUG

Ibuprofen

200 mg oral administration (RhinAdvil(R))

DRUG

Ibuprofen

200 mg oral administration (BI product)

DRUG

Pseudoephedrine-HCl

30 mg oral administration (BI product)

DRUG

Pseudoephedrine-HCl

30 mg oral administration (RhinAdvil(R))

Trial Locations (1)

Unknown

1024.7.1 Boehringer Ingelheim Investigational Site, Ingelheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY